UCP2 and cancer: Chemical induction of S-glutathionylation of uncoupling protein-2 (UCP2), which is over-expressed in several cancer types to confer resistance to oxidative distress, sensitizes drug-resistant promyelocytic leukemia cells to chemotherapeutic agents [74].